A83 AN ENZYME-LINKED IMMUNOSORBENT ASSAY FOR THERAPEUTIC DRUG MONITORING OF GOLIMUMAB

BACKGROUND: Golimumab is a therapeutic anti-TNF monoclonal antibody approved for use in moderate to severe ulcerative colitis (UC). The PURSUIT trials showed a significant exposure-response relationship of golimumab in UC. Interindividual differences in response to golimumab treatment may be explain...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Can Assoc Gastroenterol
Egile Nagusiak: Farrag, K, Berger, C, Pilch, A, Ruppert, J, Armbruster, F, Stein, J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Posters Of Distinction
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512468/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.082
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak